Loading…

H 2 S protects lipopolysaccharide-induced inflammation by blocking NFκB transactivation in endothelial cells

Hydrogen sulfide (H S) is a novel gasotransmitter and acts as a multifunctional regulator in various cellular functions. Past studies have demonstrated a significant role of H S and its generating enzyme cystathionine gamma-lyase (CSE) in the cardiovascular system. Lipopolysaccharide (LPS), a major...

Full description

Saved in:
Bibliographic Details
Published in:Toxicology and applied pharmacology 2017-11, Vol.338, p.20
Main Authors: Bourque, Caitlyn, Zhang, Yanjie, Fu, Ming, Racine, Mélanie, Greasley, Adam, Pei, Yanxi, Wu, Lingyun, Wang, Rui, Yang, Guangdong
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page
container_issue
container_start_page 20
container_title Toxicology and applied pharmacology
container_volume 338
creator Bourque, Caitlyn
Zhang, Yanjie
Fu, Ming
Racine, Mélanie
Greasley, Adam
Pei, Yanxi
Wu, Lingyun
Wang, Rui
Yang, Guangdong
description Hydrogen sulfide (H S) is a novel gasotransmitter and acts as a multifunctional regulator in various cellular functions. Past studies have demonstrated a significant role of H S and its generating enzyme cystathionine gamma-lyase (CSE) in the cardiovascular system. Lipopolysaccharide (LPS), a major pathogenic factor, is known to initiate the inflammatory immune response. The cross talk between LPS-induced inflammation and the CSE/H S system in vascular cells has not yet been elucidated in detail. Here we showed that LPS decreased CSE mRNA and protein expression in human endothelial cells and blocked H S production in mouse aorta tissues. Transfection of the cells with TLR4-specific siRNA knockdown TLR4 mRNA expression and abolished the inhibitory role of LPS on CSE expression. Higher dose of LPS (100μg/ml) decreased cell viability, which was reversed by exogenously applied H S at physiologically relevant concentration (30μM). Lower dose of LPS (10μg/ml) had no effect on cell viability, but significantly induced inflammation gene expressions and cytokines secretion and stimulated cell hyper-permeability. H S treatment prevented LPS-induced inflammation and hyper-permeability. Lower VE-cadherin expression in LPS-incubated cells would contribute to cell hyper-permeability, which was reversed by H S co-incubation. In addition, H S treatment blocked LPS-induced NFκB transactivation. We further validated that LPS-induced hyper-permeability was reversed by CSE overexpression but further deteriorated by CRISPR/Cas9-mediated knockout of CSE. In vivo, deficiency of CSE sensitized the mice to LPS-induced inflammation in vascular tissues. Take together, these data suggest that CSE/H S system protects LPS-induced inflammation and cell hyper-permeability by blocking NFκB transactivation.
format article
fullrecord <record><control><sourceid>pubmed</sourceid><recordid>TN_cdi_pubmed_primary_29128401</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>29128401</sourcerecordid><originalsourceid>FETCH-pubmed_primary_291284013</originalsourceid><addsrcrecordid>eNqFjjsKAjEUAIMg_q8g7wIL2Q_itopiZaO9ZJOoT18-JFHYq3kIz6Sg1lbTzMB02CDn9SzjZVn22TDGC-e8rqq8x_pFnRfziucDZjZQwA58cEnLFIHQO--ojULKswiodIZW3aRWgPZIwhiR0FloWmjIySvaE2zXz8cCUhD2XSW8fwy0oK1y6awJBYHURHHMukdBUU--HLHperVfbjJ_a4xWBx_QiNAefn_lX-EFW4xIIA</addsrcrecordid><sourcetype>Index Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>H 2 S protects lipopolysaccharide-induced inflammation by blocking NFκB transactivation in endothelial cells</title><source>ScienceDirect Freedom Collection 2022-2024</source><creator>Bourque, Caitlyn ; Zhang, Yanjie ; Fu, Ming ; Racine, Mélanie ; Greasley, Adam ; Pei, Yanxi ; Wu, Lingyun ; Wang, Rui ; Yang, Guangdong</creator><creatorcontrib>Bourque, Caitlyn ; Zhang, Yanjie ; Fu, Ming ; Racine, Mélanie ; Greasley, Adam ; Pei, Yanxi ; Wu, Lingyun ; Wang, Rui ; Yang, Guangdong</creatorcontrib><description>Hydrogen sulfide (H S) is a novel gasotransmitter and acts as a multifunctional regulator in various cellular functions. Past studies have demonstrated a significant role of H S and its generating enzyme cystathionine gamma-lyase (CSE) in the cardiovascular system. Lipopolysaccharide (LPS), a major pathogenic factor, is known to initiate the inflammatory immune response. The cross talk between LPS-induced inflammation and the CSE/H S system in vascular cells has not yet been elucidated in detail. Here we showed that LPS decreased CSE mRNA and protein expression in human endothelial cells and blocked H S production in mouse aorta tissues. Transfection of the cells with TLR4-specific siRNA knockdown TLR4 mRNA expression and abolished the inhibitory role of LPS on CSE expression. Higher dose of LPS (100μg/ml) decreased cell viability, which was reversed by exogenously applied H S at physiologically relevant concentration (30μM). Lower dose of LPS (10μg/ml) had no effect on cell viability, but significantly induced inflammation gene expressions and cytokines secretion and stimulated cell hyper-permeability. H S treatment prevented LPS-induced inflammation and hyper-permeability. Lower VE-cadherin expression in LPS-incubated cells would contribute to cell hyper-permeability, which was reversed by H S co-incubation. In addition, H S treatment blocked LPS-induced NFκB transactivation. We further validated that LPS-induced hyper-permeability was reversed by CSE overexpression but further deteriorated by CRISPR/Cas9-mediated knockout of CSE. In vivo, deficiency of CSE sensitized the mice to LPS-induced inflammation in vascular tissues. Take together, these data suggest that CSE/H S system protects LPS-induced inflammation and cell hyper-permeability by blocking NFκB transactivation.</description><identifier>EISSN: 1096-0333</identifier><identifier>PMID: 29128401</identifier><language>eng</language><publisher>United States</publisher><ispartof>Toxicology and applied pharmacology, 2017-11, Vol.338, p.20</ispartof><rights>Copyright © 2017 Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29128401$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Bourque, Caitlyn</creatorcontrib><creatorcontrib>Zhang, Yanjie</creatorcontrib><creatorcontrib>Fu, Ming</creatorcontrib><creatorcontrib>Racine, Mélanie</creatorcontrib><creatorcontrib>Greasley, Adam</creatorcontrib><creatorcontrib>Pei, Yanxi</creatorcontrib><creatorcontrib>Wu, Lingyun</creatorcontrib><creatorcontrib>Wang, Rui</creatorcontrib><creatorcontrib>Yang, Guangdong</creatorcontrib><title>H 2 S protects lipopolysaccharide-induced inflammation by blocking NFκB transactivation in endothelial cells</title><title>Toxicology and applied pharmacology</title><addtitle>Toxicol Appl Pharmacol</addtitle><description>Hydrogen sulfide (H S) is a novel gasotransmitter and acts as a multifunctional regulator in various cellular functions. Past studies have demonstrated a significant role of H S and its generating enzyme cystathionine gamma-lyase (CSE) in the cardiovascular system. Lipopolysaccharide (LPS), a major pathogenic factor, is known to initiate the inflammatory immune response. The cross talk between LPS-induced inflammation and the CSE/H S system in vascular cells has not yet been elucidated in detail. Here we showed that LPS decreased CSE mRNA and protein expression in human endothelial cells and blocked H S production in mouse aorta tissues. Transfection of the cells with TLR4-specific siRNA knockdown TLR4 mRNA expression and abolished the inhibitory role of LPS on CSE expression. Higher dose of LPS (100μg/ml) decreased cell viability, which was reversed by exogenously applied H S at physiologically relevant concentration (30μM). Lower dose of LPS (10μg/ml) had no effect on cell viability, but significantly induced inflammation gene expressions and cytokines secretion and stimulated cell hyper-permeability. H S treatment prevented LPS-induced inflammation and hyper-permeability. Lower VE-cadherin expression in LPS-incubated cells would contribute to cell hyper-permeability, which was reversed by H S co-incubation. In addition, H S treatment blocked LPS-induced NFκB transactivation. We further validated that LPS-induced hyper-permeability was reversed by CSE overexpression but further deteriorated by CRISPR/Cas9-mediated knockout of CSE. In vivo, deficiency of CSE sensitized the mice to LPS-induced inflammation in vascular tissues. Take together, these data suggest that CSE/H S system protects LPS-induced inflammation and cell hyper-permeability by blocking NFκB transactivation.</description><issn>1096-0333</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><recordid>eNqFjjsKAjEUAIMg_q8g7wIL2Q_itopiZaO9ZJOoT18-JFHYq3kIz6Sg1lbTzMB02CDn9SzjZVn22TDGC-e8rqq8x_pFnRfziucDZjZQwA58cEnLFIHQO--ojULKswiodIZW3aRWgPZIwhiR0FloWmjIySvaE2zXz8cCUhD2XSW8fwy0oK1y6awJBYHURHHMukdBUU--HLHperVfbjJ_a4xWBx_QiNAefn_lX-EFW4xIIA</recordid><startdate>20171108</startdate><enddate>20171108</enddate><creator>Bourque, Caitlyn</creator><creator>Zhang, Yanjie</creator><creator>Fu, Ming</creator><creator>Racine, Mélanie</creator><creator>Greasley, Adam</creator><creator>Pei, Yanxi</creator><creator>Wu, Lingyun</creator><creator>Wang, Rui</creator><creator>Yang, Guangdong</creator><scope>NPM</scope></search><sort><creationdate>20171108</creationdate><title>H 2 S protects lipopolysaccharide-induced inflammation by blocking NFκB transactivation in endothelial cells</title><author>Bourque, Caitlyn ; Zhang, Yanjie ; Fu, Ming ; Racine, Mélanie ; Greasley, Adam ; Pei, Yanxi ; Wu, Lingyun ; Wang, Rui ; Yang, Guangdong</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-pubmed_primary_291284013</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bourque, Caitlyn</creatorcontrib><creatorcontrib>Zhang, Yanjie</creatorcontrib><creatorcontrib>Fu, Ming</creatorcontrib><creatorcontrib>Racine, Mélanie</creatorcontrib><creatorcontrib>Greasley, Adam</creatorcontrib><creatorcontrib>Pei, Yanxi</creatorcontrib><creatorcontrib>Wu, Lingyun</creatorcontrib><creatorcontrib>Wang, Rui</creatorcontrib><creatorcontrib>Yang, Guangdong</creatorcontrib><collection>PubMed</collection><jtitle>Toxicology and applied pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bourque, Caitlyn</au><au>Zhang, Yanjie</au><au>Fu, Ming</au><au>Racine, Mélanie</au><au>Greasley, Adam</au><au>Pei, Yanxi</au><au>Wu, Lingyun</au><au>Wang, Rui</au><au>Yang, Guangdong</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>H 2 S protects lipopolysaccharide-induced inflammation by blocking NFκB transactivation in endothelial cells</atitle><jtitle>Toxicology and applied pharmacology</jtitle><addtitle>Toxicol Appl Pharmacol</addtitle><date>2017-11-08</date><risdate>2017</risdate><volume>338</volume><spage>20</spage><pages>20-</pages><eissn>1096-0333</eissn><abstract>Hydrogen sulfide (H S) is a novel gasotransmitter and acts as a multifunctional regulator in various cellular functions. Past studies have demonstrated a significant role of H S and its generating enzyme cystathionine gamma-lyase (CSE) in the cardiovascular system. Lipopolysaccharide (LPS), a major pathogenic factor, is known to initiate the inflammatory immune response. The cross talk between LPS-induced inflammation and the CSE/H S system in vascular cells has not yet been elucidated in detail. Here we showed that LPS decreased CSE mRNA and protein expression in human endothelial cells and blocked H S production in mouse aorta tissues. Transfection of the cells with TLR4-specific siRNA knockdown TLR4 mRNA expression and abolished the inhibitory role of LPS on CSE expression. Higher dose of LPS (100μg/ml) decreased cell viability, which was reversed by exogenously applied H S at physiologically relevant concentration (30μM). Lower dose of LPS (10μg/ml) had no effect on cell viability, but significantly induced inflammation gene expressions and cytokines secretion and stimulated cell hyper-permeability. H S treatment prevented LPS-induced inflammation and hyper-permeability. Lower VE-cadherin expression in LPS-incubated cells would contribute to cell hyper-permeability, which was reversed by H S co-incubation. In addition, H S treatment blocked LPS-induced NFκB transactivation. We further validated that LPS-induced hyper-permeability was reversed by CSE overexpression but further deteriorated by CRISPR/Cas9-mediated knockout of CSE. In vivo, deficiency of CSE sensitized the mice to LPS-induced inflammation in vascular tissues. Take together, these data suggest that CSE/H S system protects LPS-induced inflammation and cell hyper-permeability by blocking NFκB transactivation.</abstract><cop>United States</cop><pmid>29128401</pmid></addata></record>
fulltext fulltext
identifier EISSN: 1096-0333
ispartof Toxicology and applied pharmacology, 2017-11, Vol.338, p.20
issn 1096-0333
language eng
recordid cdi_pubmed_primary_29128401
source ScienceDirect Freedom Collection 2022-2024
title H 2 S protects lipopolysaccharide-induced inflammation by blocking NFκB transactivation in endothelial cells
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T14%3A27%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=H%202%20S%20protects%20lipopolysaccharide-induced%20inflammation%20by%20blocking%20NF%CE%BAB%20transactivation%20in%20endothelial%20cells&rft.jtitle=Toxicology%20and%20applied%20pharmacology&rft.au=Bourque,%20Caitlyn&rft.date=2017-11-08&rft.volume=338&rft.spage=20&rft.pages=20-&rft.eissn=1096-0333&rft_id=info:doi/&rft_dat=%3Cpubmed%3E29128401%3C/pubmed%3E%3Cgrp_id%3Ecdi_FETCH-pubmed_primary_291284013%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/29128401&rfr_iscdi=true